What amount sold does JENOP GLOBAL HEALTHCARE FUND Ltd report in Form D filings?

The latest linked filings report $500.4M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was JENOP GLOBAL HEALTHCARE FUND Ltd's most recent SEC filing?

JENOP GLOBAL HEALTHCARE FUND Ltd's most recent Form D filing was on 2026-02-17.

How many investors does JENOP GLOBAL HEALTHCARE FUND Ltd have?

The most recent Form D filing lists 128 investor(s).

What type of securities does JENOP GLOBAL HEALTHCARE FUND Ltd offer?

JENOP GLOBAL HEALTHCARE FUND Ltd's SEC Form D filings indicate equity offerings.

JENOP GLOBAL HEALTHCARE FUND Ltd

CIK: 0001562185·Pooled Investment Fund·PEMBROKE, D0·Other

Reported Sold

$500,371,688

Total Filings

Identified Offerings

Last Filed

Feb 17, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Feb 17, 2026Form D/A — Amendment

Reported sold: $500,371,688 · Target: Indefinite

Rule 506(c)·128 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Nov 26, 2024Form D/A — Amendment

Reported sold: $497,881,689 · Target: Indefinite

Rule 506(c)·119 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Nov 26, 2024Form D/A — Amendment

Reported sold: $497,881,688 · Target: Indefinite

Rule 506(c)·125 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Nov 29, 2023Form D/A — Amendment

Reported sold: $447,235,558 · Target: Indefinite

Rule 506(c)·113 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Nov 28, 2022Form D/A — Amendment

Reported sold: $446,011,724 · Target: Indefinite

Rule 506(c)·111 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Nov 15, 2021Form D/A — Amendment

Reported sold: $436,922,532 · Target: Indefinite

Rule 506(c)·93 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Nov 30, 2020Form D/A — Amendment

Reported sold: $435,922,532 · Target: Indefinite

Rule 506(c)·92 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Exemptions

Jan 29, 2020Form D/A — Amendment

Reported sold: $59,535,887 · Target: Indefinite

Rule 506(c)·27 investors·Section 3(c), Section 3(c)(7)

Changed: Exemptions

Nov 25, 2019Form D/A — Amendment

Reported sold: $59,535,887 · Target: Indefinite

Rule 506(b)·27 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Oct 5, 2018Form D/A — Amendment

Reported sold: $28,335,000 · Target: Indefinite

Rule 506(b)·30 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Jan 24, 2018Form D/A — Amendment

Reported sold: $20,634,000 · Target: Indefinite

Rule 506(b)·29 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Nov 9, 2016Form D/A — Amendment

Reported sold: $33,747,000 · Target: Indefinite

Rule 506(b)·52 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Oct 30, 2015Form D/A — Amendment

Reported sold: $57,744,000 · Target: Indefinite

Rule 506(b)·55 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Oct 30, 2014Form D/A — Amendment

Reported sold: $36,716,000 · Target: Indefinite

Rule 506(b)·42 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Sales commissions

Oct 1, 2013Form D/A — Amendment

Reported sold: $24,686,000 · Target: Indefinite

Rule 506(b)·35 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Exemptions

Nov 28, 2012Form D/A — Amendment

Reported sold: $13,745,000 · Target: Indefinite

Rule 506·25 investors·Section 3(c), Section 3(c)(7)

Changed: Exemptions

Nov 14, 2012Form D — New notice

Reported sold: $13,745,000 · Target: Indefinite

Section 3(c)·25 investors·Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

128

Revenue Range

—

Reported commissions across identified offerings

$1,287

Amendment Rate

94%

Latest reported sold across 1 identified offering

$500,371,688

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Geoffrey Manfred Lewis

Related Person

Appears on 15 filings

Kenneth Moore

Related Person

Appears on 15 filings

Thomas Haskins Davis

Related Person

Appears on 10 filings

Neil Glass

Related Person

Appears on 9 filings

Optima Managers LLC

Related Person

Appears on 9 filings

Thomas Haskins Davis

Related Person

Appears on 5 filings

Neil Glass

Related Person

Appears on 5 filings

Optima Management Partners L.P.

Related Person

Appears on 4 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 17, 2026	Amendment	Indefinite	$500,371,688	128
Nov 26, 2024	Amendment	Indefinite	$497,881,689	119
Nov 26, 2024	Amendment	Indefinite	$497,881,688	125
Nov 29, 2023	Amendment	Indefinite	$447,235,558	113
Nov 28, 2022	Amendment	Indefinite	$446,011,724	111
Nov 15, 2021	Amendment	Indefinite	$436,922,532	93
Nov 30, 2020	Amendment	Indefinite	$435,922,532	92
Jan 29, 2020	Amendment	Indefinite	$59,535,887	27
Nov 25, 2019	Amendment	Indefinite	$59,535,887	27
Oct 5, 2018	Amendment	Indefinite	$28,335,000	30
Jan 24, 2018	Amendment	Indefinite	$20,634,000	29
Nov 9, 2016	Amendment	Indefinite	$33,747,000	52
Oct 30, 2015	Amendment	Indefinite	$57,744,000	55
Oct 30, 2014	Amendment	Indefinite	$36,716,000	42
Oct 1, 2013	Amendment	Indefinite	$24,686,000	35
Nov 28, 2012	Amendment	Indefinite	$13,745,000	25
Nov 14, 2012	New	Indefinite	$13,745,000	25

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Maple Leaf Fund Ltd.

Pooled Investment Fund

Offering target: Indefinite

Filed Oct 21, 2026